📰 off-dutyCNBCMonday, July 20, 2026 at 2:12 AM UTC4d ago

Samsung Biologics makes $1.8 billion all-cash offer for Switzerland's PolyPeptide Group

South Korea's Samsung Biologics said on Monday that it had made an all-cash bid of 1.46 billion Swiss francs ($1.8 billion) for Switzerland's PolyPeptide Group

Read full article at CNBC →

Originally published by CNBC. Summary and curation by DutyStation.ai.

← Back to Military News

Samsung Biologics makes $1.8 billion all-cash offer for Switzerland's PolyPeptide Group

📍 Related Duty Stations

📰 Related Stories

U.S. to see higher generic drug prices thanks to tariffs, CEO of leading India pharma firm warns

Amazon cracks down on use of AI images by sellers after New York law

Allianz to buy HSBC’s Singapore insurance unit for $2.09 billion

Meet the judges who will crown Australia’s next breakout startup

Parris Island drill instructor found dead in apartment

Intel's turnaround under CEO Lip-Bu Tan gains steam with another strong quarter